These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26615769)

  • 1. Impact of donor and recipient hepatitis C status in lung transplantation.
    Englum BR; Ganapathi AM; Speicher PJ; Gulack BC; Snyder LD; Davis RD; Hartwig MG
    J Heart Lung Transplant; 2016 Feb; 35(2):228-35. PubMed ID: 26615769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
    Gasink LB; Blumberg EA; Localio AR; Desai SS; Israni AK; Lautenbach E
    JAMA; 2006 Oct; 296(15):1843-50. PubMed ID: 17047214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients.
    Kucirka LM; Peters TG; Segev DL
    Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data.
    Gupta G; Kang L; Yu JW; Limkemann AJ; Garcia V; Bandyopadhyay D; Kumar D; Fattah H; Levy M; Cotterell AH; Sharma A; Bhati C; Reichman T; King AL; Sterling R
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28712111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor and Recipient Hepatitis C Status Does Not Affect Rejection in Thoracic Transplantation.
    Ganapathi AM; Whitson BA; Heh V; Keller BC; Smith SA; Mokadam NA; Henn MC
    Ann Thorac Surg; 2023 Jan; 115(1):221-230. PubMed ID: 35940315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of liver grafts procured from hepatitis C-positive donors.
    Velidedeoglu E; Desai NM; Campos L; Olthoff KM; Shaked A; Nunes F; Zeldin G; Stewart C; Blumberg E; Abrams J; Markmann JF
    Transplantation; 2002 Feb; 73(4):582-7. PubMed ID: 11889435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hepatitis B core antibody positive donors in lung and heart-lung transplantation: an analysis of the United Network For Organ Sharing Database.
    Dhillon GS; Levitt J; Mallidi H; Valentine VG; Gupta MR; Sista R; Weill D
    Transplantation; 2009 Sep; 88(6):842-6. PubMed ID: 19920785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis C infection on outcomes after heart transplantation.
    Fong TL; Hou L; Hutchinson IV; Cicciarelli JC; Cho YW
    Transplantation; 2009 Nov; 88(9):1137-41. PubMed ID: 19898211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD
    Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation.
    Cotter TG; Aronsohn A; Reddy KG; Charlton M
    Transplantation; 2021 Jun; 105(6):1285-1290. PubMed ID: 32639400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry.
    Koenig A; Stepanova M; Saab S; Ahmed A; Wong R; Younossi ZM
    Aliment Pharmacol Ther; 2016 Aug; 44(3):271-8. PubMed ID: 27279496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database).
    Kumar S; Deo SV; Altarabsheh SE; Dunlay SM; Sarabu N; Sareyyupoglu B; Elgudin Y; Medalion B; ElAmm C; Ginwalla M; Zacharias M; Benatti R; Oliveira GH; Kilic A; Fonarow GC; Park SJ
    Am J Cardiol; 2016 Jul; 118(1):132-7. PubMed ID: 27189814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after lung transplantation and practices of lung transplant programs in the United States regarding hepatitis C seropositive recipients.
    Fong TL; Cho YW; Hou L; Hutchinson IV; Barbers RG; Herrington CS
    Transplantation; 2011 Jun; 91(11):1293-6. PubMed ID: 21516068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.
    Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
    Transplant Proc; 2012 Sep; 44(7):1960-2. PubMed ID: 22974882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes.
    Kim ST; Xia Y; Ho JK; Lowery E; McCarthy DP; Ardehali A
    J Heart Lung Transplant; 2024 Feb; 43(2):337-345. PubMed ID: 37866469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended criteria donor lungs and clinical outcome: results of an alternative allocation algorithm.
    Sommer W; Kühn C; Tudorache I; Avsar M; Gottlieb J; Boethig D; Haverich A; Warnecke G
    J Heart Lung Transplant; 2013 Nov; 32(11):1065-72. PubMed ID: 23953918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant outcomes of patients with and without hepatitis C virus infection according to donor age and gender matching.
    Grąt M; Kornasiewicz O; Lewandowski Z; Ligocka J; Grąt K; Wronka KM; Zieniewicz K; Krawczyk M
    Ann Transplant; 2013 Dec; 18():705-15. PubMed ID: 24361968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.